Report Detail
Global Research Antibodies Market - Premium Insight, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q2 2018 Update)
- RnM2798466 |
- 14 March, 2019 |
- Global |
- 147 Pages |
- 360iResearch |
- Other
The global research antibodies market is expected to grow from USD 88,721.57 million 2017 to USD 131,831.57 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 5.82%.
“Increasing research and development activity and fundingis one of the factors largely attributing to the growth of research antibodies market globally”
The factors attributing to the growth of the market are increasing research and development activity and funding, increasing focus in stem cell and neurobiology research, and collaborations between industry and academics. However, some factors such as and time and cost consuming antibody development processes may hinder the market growth. The global research antibodies market is expected to showcase the opportunities such as biomarker discovery gaining attractive market edge, increasing demand for protein therapeutics and personalized medicine, and growth prospects in emerging markets. In the near future, the market may face the possible challenges in the growth due to quality concerns, and pricing pressure. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global research antibodies market market.
On the basis of function, the global research antibodies market is studied across Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem Cells.
On the basis of operation, the global research antibodies market is studied across Drug Development, Genomics, and Proteomics.
On the basis of product, the global research antibodies market is studied across Monoclonal Antibodies and Polyclonal Antibodies.
On the basis of source, the global research antibodies market is studied across Goat, Mouse, and Rabbit.
On the basis of technology, the global research antibodies market is studied across Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, and Western Blotting.
On the basis of type, the global research antibodies market is studied across Primary Antibodies and Secondary Antibodies.
On the basis of end user, the global research antibodies market is studied across Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.
On the basis of geography, the global research antibodies market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).
“Abcam PLC: The potential growing player for the global research antibodies market”
The key players profiled in the global research antibodies market are Abcam PLC, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biolegend, Inc., Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, GenScript Corporation, Lonza Group, Merck Group, Perkin Elmer, Inc., QIAGEN, Inc., Sysmex Corporation, and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global research antibodies market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global research antibodies market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global research antibodies market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global research antibodies market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global research antibodies market.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Stakeholders
2. Research & Forecasting
- 2.1. Research Methodology
- 2.1.1. Research Instruments
- 2.1.1.1. Secondary Instrument
- 2.1.1.2. Primary Instrument
- 2.1.2. Research Approaches
- 2.1.2.1. Bottom-up Approach
- 2.1.2.2. Top-down Approach
- 2.1.3. Research Reliability & Validity
- 2.1.4. Research Assumptions
- 2.1.5. Vendor Inclusion Criteria
- 2.1.1. Research Instruments
- 2.2. Forecasting Methodology
- 2.2.1. Methodology for Market Estimation & Forecasting
- 2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
- 4.1. Market Connectivity
- 4.2. Market Data Feed
- 4.3. Market Vendor Ranking Analysis
- 4.4. Market Dynamics
- 4.4.1. Drivers
- 4.4.1.1. Increasing research and development activity and funding
- 4.4.1.2. Increasing focus in Stem Cell and Neurobiology Research
- 4.4.1.3. Collaborations between industry and academics
- 4.4.2. Restraints
- 4.4.2.1. Time and cost consuming antibody development processes
- 4.4.3. Opportunities
- 4.4.3.1. Biomarker Discovery gaining attractive market edge
- 4.4.3.2. Increasing demand for Protein Therapeutics and Personalized Medicine
- 4.4.3.3. Growth prospects in emerging markets
- 4.4.4. Challenges
- 4.4.4.1. Quality concerns
- 4.4.4.2. Pricing pressure
- 4.4.1. Drivers
- 4.5. Porter’s Five Forces Analysis
- 4.5.1. Threat of New Entrants
- 4.5.2. Threat of Substitutes
- 4.5.3. Bargaining Power of Customers
- 4.5.4. Bargaining Power of Suppliers
- 4.5.5. Industry Rivalry
5. Global Research Antibodies Market, by Function
- 5.1. Introduction
- 5.2. Immunology
- 5.3. Infectious Diseases
- 5.4. Neurobiology
- 5.5. Oncology
- 5.6. Stem Cells
6. Global Research Antibodies Market, by Operation
- 6.1. Introduction
- 6.2. Drug Development
- 6.3. Genomics
- 6.4. Proteomics
7. Global Research Antibodies Market, by Product
- 7.1. Introduction
- 7.2. Monoclonal Antibodies
- 7.3. Polyclonal Antibodies
8. Global Research Antibodies Market, by Source
- 8.1. Introduction
- 8.2. Goat
- 8.3. Mouse
- 8.4. Rabbit
9. Global Research Antibodies Market, by Technology
- 9.1. Introduction
- 9.2. Enzyme-linked Immunosorbent Assay
- 9.3. Flow Cytometry
- 9.4. Immunofluorescence
- 9.5. Immunohistochemistry
- 9.6. Immunoprecipitation
- 9.7. Western Blotting
10. Global Research Antibodies Market, by Type
- 10.1. Introduction
- 10.2. Primary Antibodies
- 10.3. Secondary Antibodies
11. Global Research Antibodies Market, by End User
- 11.1. Introduction
- 11.2. Academic & Research Institutes
- 11.3. Pharmaceutical & Biotechnology Companies
12. Global Research Antibodies Market, by Geography
- 12.1. Introduction
- 12.2. Americas Research Antibodies Market
- 12.2.1. Americas Research Antibodies Market, by Country
- 12.2.1.1. United States
- 12.2.1.2. Brazil
- 12.2.1.3. Canada
- 12.2.1.4. Mexico
- 12.2.1.5. Argentina
- 12.2.2. Americas Research Antibodies Market, by Function
- 12.2.3. Americas Research Antibodies Market, by Operation
- 12.2.4. Americas Research Antibodies Market, by Product
- 12.2.5. Americas Research Antibodies Market, by Source
- 12.2.6. Americas Research Antibodies Market, by Technology
- 12.2.7. Americas Research Antibodies Market, by Type
- 12.2.8. Americas Research Antibodies Market, by End User
- 12.2.1. Americas Research Antibodies Market, by Country
- 12.3. Europe, Middle East & Africa Research Antibodies Market
- 12.3.1. Europe, Middle East & Africa Research Antibodies Market, by Country
- 12.3.1.1. United Kingdom
- 12.3.1.2. Germany
- 12.3.1.3. France
- 12.3.1.4. Saudi Arabia
- 12.3.1.5. United Arab Emirates
- 12.3.1.6. Italy
- 12.3.1.7. Russia
- 12.3.2. Europe, Middle East & Africa Research Antibodies Market, by Function
- 12.3.3. Europe, Middle East & Africa Research Antibodies Market, by Operation
- 12.3.4. Europe, Middle East & Africa Research Antibodies Market, by Product
- 12.3.5. Europe, Middle East & Africa Research Antibodies Market, by Source
- 12.3.6. Europe, Middle East & Africa Research Antibodies Market, by Technology
- 12.3.7. Europe, Middle East & Africa Research Antibodies Market, by Type
- 12.3.8. Europe, Middle East & Africa Research Antibodies Market, by End User
- 12.3.1. Europe, Middle East & Africa Research Antibodies Market, by Country
- 12.4. Asia-Pacific Research Antibodies Market
- 12.4.1. Asia-Pacific Research Antibodies Market, by Country
- 12.4.1.1. China
- 12.4.1.2. Japan
- 12.4.1.3. India
- 12.4.1.4. Australia
- 12.4.2. Asia-Pacific Research Antibodies Market, by Function
- 12.4.3. Asia-Pacific Research Antibodies Market, by Operation
- 12.4.4. Asia-Pacific Research Antibodies Market, by Product
- 12.4.5. Asia-Pacific Research Antibodies Market, by Source
- 12.4.6. Asia-Pacific Research Antibodies Market, by Technology
- 12.4.7. Asia-Pacific Research Antibodies Market, by Type
- 12.4.8. Asia-Pacific Research Antibodies Market, by End User
- 12.4.1. Asia-Pacific Research Antibodies Market, by Country
13. Competitive Strategic Window
- 13.1. Introduction
- 13.1.1. Leverage Zone
- 13.1.2. Vantage Zone
- 13.1.3. Speculative Zone
- 13.1.4. Bottleneck Zone
14. FPNV Positioning Matrix
- 14.1. Introduction
- 14.2. Scores
- 14.2.1. Forefront
- 14.2.2. Pathfinders
- 14.2.3. Niche
- 14.2.4. Vital
- 14.3. Business Strategy
- 14.4. Product Satisfaction
15. Competitive News Feed Analysis
16. Company Usability Profiles
- 16.1. Abcam PLC
- 16.2. Agilent Technologies, Inc.
- 16.3. Becton, Dickinson and Company
- 16.4. Bio-Rad Laboratories, Inc.
- 16.5. Biolegend, Inc.
- 16.6. Cell Signaling Technology, Inc.
- 16.7. Danaher Corporation
- 16.8. F. Hoffmann-La Roche AG
- 16.9. GenScript Corporation
- 16.10. Lonza Group
- 16.11. Merck Group
- 16.12. Perkin Elmer, Inc.
- 16.13. QIAGEN, Inc.
- 16.14. Sysmex Corporation
- 16.15. Thermo Fisher Scientific, Inc.
17. Appendix
- 17.1. Top Reports
- 17.2. Author Details
LIST OF TABLES (63 TABLES)
TABLE 1. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. GLOBAL RESEARCH ANTIBODIES MARKET RANKING, BY VENDORS, 2017
TABLE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2016 - 2024 (USD MILLION)
TABLE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 21. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 22. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 23. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 24. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 25. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 26. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 27. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 28. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 29. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 30. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 31. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 32. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 33. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 34. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 35. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2016 - 2024 (USD MILLION)
TABLE 36. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2016 - 2024 (USD MILLION)
TABLE 37. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 38. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2016 - 2024 (USD MILLION)
TABLE 39. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 40. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 41. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2016 - 2024 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2016 - 2024 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2016 - 2024 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 50. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 51. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2016 - 2024 (USD MILLION)
TABLE 52. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2016 - 2024 (USD MILLION)
TABLE 53. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 54. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2016 - 2024 (USD MILLION)
TABLE 55. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 56. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 57. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 58. 360IRESEARCH SCORES FOR FOREFRONT IN RESEARCH ANTIBODIES MARKET
TABLE 59. 360IRESEARCH SCORES FOR PATHFINDERS IN RESEARCH ANTIBODIES MARKET
TABLE 60. 360IRESEARCH SCORES FOR NICHE IN RESEARCH ANTIBODIES MARKET
TABLE 61. 360IRESEARCH SCORES FOR VITAL IN RESEARCH ANTIBODIES MARKET
TABLE 62. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR RESEARCH ANTIBODIES MARKET
TABLE 63. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR RESEARCH ANTIBODIES MARKET
LIST OF FIGURES (51 TABLES)
FIGURE 1. GLOBAL RESEARCH ANTIBODIES MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL RESEARCH ANTIBODIES MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL RESEARCH ANTIBODIES MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL RESEARCH ANTIBODIES MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL RESEARCH ANTIBODIES MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL RESEARCH ANTIBODIES MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL RESEARCH ANTIBODIES MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL RESEARCH ANTIBODIES MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL RESEARCH ANTIBODIES MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. RESEARCH ANTIBODIES MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2017 VS 2024 (USD MILLION)
FIGURE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2017 VS 2024 (USD MILLION)
FIGURE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 21. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 22. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2017 VS 2024 (USD MILLION)
FIGURE 23. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 24. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 25. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2017 VS 2024 (USD MILLION)
FIGURE 26. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 27. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 28. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 29. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD MILLION)
FIGURE 30. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 31. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 32. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 33. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 34. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 35. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 36. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2017 VS 2024 (USD MILLION)
FIGURE 37. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 38. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 39. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2017 VS 2024 (USD MILLION)
FIGURE 40. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 41. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 42. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 43. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESEARCH ANTIBODIES MARKET, BY FUNCTION, 2024
FIGURE 44. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESEARCH ANTIBODIES MARKET, BY OPERATION, 2024
FIGURE 45. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT, 2024
FIGURE 46. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESEARCH ANTIBODIES MARKET, BY SOURCE, 2024
FIGURE 47. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY, 2024
FIGURE 48. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESEARCH ANTIBODIES MARKET, BY TYPE, 2024
FIGURE 49. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER, 2024
FIGURE 50. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESEARCH ANTIBODIES MARKET, BY GEOGRAPHY, 2024
FIGURE 51. 360IRESEARCH FPNV POSITIONING MATRIX FOR RESEARCH ANTIBODIES MARKET
Summary:
Get latest Market Research Reports on Research Antibodies . Industry analysis & Market Report on Research Antibodies is a syndicated market report, published as Global Research Antibodies Market - Premium Insight, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q2 2018 Update). It is complete Research Study and Industry Analysis of Research Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
